Issued Patents All Time
Showing 1–12 of 12 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421206 | Aryl-n-aryl derivatives for treating a RNA virus infection | Didier Scherrer, Jamal Tazi, Romain Najman, Julien SANTO, Cécile Apolit | 2025-09-23 |
| 12247018 | Aryl-n-aryl derivatives for treating a RNA virus infection | Didier Scherrer, Jamal Tazi, Romain Najman, Julien SANTO, Cécile Apolit | 2025-03-11 |
| 12084422 | Phenyl-n-quinoline derivatives for treating a RNA virus infection | Didier Scherrer, Jamal Tazi, Romain Najman, Julien SANTO, Cécile Apolit | 2024-09-10 |
| 11739073 | Aryl-n-aryl derivatives for treating a RNA virus infection | Didier Scherrer, Jamal Tazi, Romain Najman, Julien SANTO, Cécile Apolit | 2023-08-29 |
| 11441181 | miRNA-124 as a biomarker | Jamal Tazi, Didier Scherrer, Aude Garcel, Noelie Campos, Romain Najman | 2022-09-13 |
| 10654813 | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies | Jamal Tazi, David Grierson, Pierre Roux | 2020-05-19 |
| 10130595 | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies | Jamal Tazi, David Grierson, Pierre Roux | 2018-11-20 |
| 9827237 | Compounds useful for treating diseases caused by retroviruses | Jamal Tazi, Romain Najman, Didier Scherrer, Noelie Campos, Aude Garcel | 2017-11-28 |
| 9556489 | Use of RBM39 as a biomaker | Jamal Tazi, Julian Venables, Aude Garcel, Noëlle Campos, Romain Najman +1 more | 2017-01-31 |
| 9233931 | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies | Jamal Tazi, David Grierson, Pierre Roux | 2016-01-12 |
| 8895726 | Compounds derived from indole and pharmaceutical compositions containing them | Fabrice Lejeune, Jamal Tazi, David Grierson, Christian Rivalle | 2014-11-25 |
| 8604063 | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies | Jamal Tazi, David Grierson, Pierre Roux | 2013-12-10 |